{
  "catalogId": "1d2e99ab-07e2-4251-846d-ca619a0f8d72",
  "name": "RETEVMO 40 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "171 67 37212 99",
  "treatmentDescriptions": "Metastatic RET Fusion-Positive Non-Small Cell Lung CancerRETEVMO is indicated for the treatment of adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC).RET-Mutant Medullary Thyroid CancerRETEVMO is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) who require systemic therapy.RET Fusion-Positive Thyroid CancerRETEVMO is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate).Other RET Fusion-Positive Solid TumorsRETEVMO is indicated for the treatment of adult patients with locally advanced or metastatic solid tumors with a RET gene fusion that have progressed on or following prior systemic treatment or who have no satisfactory alternative treatment options.",
  "termsOfIssue": "Prescription required",
  "form": "tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "SELPERCATINIB",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L01EX22",
      "name": "SELPERCATINIB"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "RETEVMO 40 MG 60 CAPS",
      "manufacturer": {
        "name": "אלי לילי",
        "countryOfOrigin": "IL"
      },
      "strength": [
        {
          "value": 40.0,
          "unit": "mg"
        }
      ],
      "quantity": {
        "value": 60.0,
        "unit": "units"
      },
      "packagingDescription": "BOTTLE HDPE",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "9243",
        "yarpa": "22189",
        "pharmasoft": "18716"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 8307.267795,
        "retailMargin": 10.0,
        "maxRetailPrice": 9137.994575,
        "maxPriceWithVAT": 10782.83312
      },
      "formulation": ""
    }
  ],
  "metadata": {
    "version": "1.5",
    "lastUpdated": "2025-08-01T18:03:50.848247",
    "tags": [],
    "smartValidation": {
      "extractedFrom": "RETEVMO 40 MG 60 CAPS",
      "processedBy": "smart_validation",
      "matchScore": 0.8300000000000001,
      "status": "corrected",
      "correctedAt": "2025-08-01T16:14:51.104641",
      "previousRegistration": "179 73 38201 99",
      "newRegistration": "171 67 37212 99",
      "apiSource": "RETEVMO 40 MG"
    }
  },
  "nameHebrew": "רטבמו 40 מ\"ג",
  "registrationDate": "2023-01-30"
}